Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping

Triple-negative breast cancer (TNBC) is a heterogeneous disease with diverse, often poor prognoses and treatment responses. In order to identify targetable biomarkers and guide personalized care, scientists have developed multiple molecular classification systems for TNBC based on transcriptomic pro...

Full description

Bibliographic Details
Main Authors:	Xinjian Yu, Yongjing Liu, Ming Chen
Format:	Article
Language:	English
Published:	MDPI AG 2022-05-01
Series:	Cancers
Subjects:	triple-negative breast cancer molecular subtype subtyping benchmark microarrays clustering biomarker discovery
Online Access:	https://www.mdpi.com/2072-6694/14/11/2571

Similar Items

The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
by: Lijuan Weng, et al.
Published: (2024-03-01)

Triple-negative breast cancer molecular subtyping and treatment progress
by: Li Yin, et al.
Published: (2020-06-01)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
by: Marisa Leeha, et al.
Published: (2023-05-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
by: Mohammed Amrallah A., et al.
Published: (2021-05-01)

Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
by: Miquel Ensenyat-Mendez, et al.
Published: (2021-06-01)

New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer
by: Brahim El Hejjioui, et al.
Published: (2023-06-01)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
by: Pascal Jézéquel, et al.
Published: (2019-05-01)

Triple-Negative Breast Cancer: One Or More Entities?
by: Matikas Alexios, et al.
Published: (2014-12-01)

Recent advances in targeted strategies for triple-negative breast cancer
by: Shuangli Zhu, et al.
Published: (2023-08-01)

Triple Negative Breast Cancer Characteristics Based on Basal-like and Non-Basal-like Subtypes
by: Fifi Akwarini, et al.
Published: (2019-05-01)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
by: David P. Hill, et al.
Published: (2019-11-01)

Prognostic Markers in Tyrosine Kinases Specific to Basal-like 2 Subtype of Triple-Negative Breast Cancer
by: Praopim Limsakul, et al.
Published: (2024-01-01)

Molecular breast cancer subtypes prevalence in an indigenous Sub Saharan African population
by: Moses Galukande, et al.
Published: (2014-04-01)

Tumor Characteristics Associated with Axillary Nodal Positivity in Triple Negative Breast Cancer
by: Neha Chintapally, et al.
Published: (2023-09-01)

Components of the tumor immune microenvironment based on m‐IHC correlate with prognosis and subtype of triple‐negative breast cancer
by: Luyi Lin, et al.
Published: (2023-12-01)

CSA Antisense Targeting Enhances Anticancer Drug Sensitivity in Breast Cancer Cells, including the Triple-Negative Subtype
by: Silvia Filippi, et al.
Published: (2022-03-01)

Identification of molecular subtypes and a six-gene risk model related to cuproptosis for triple negative breast cancer
by: Baoxi Zhu, et al.
Published: (2022-10-01)

Extracellular Vesicles in Triple–Negative Breast Cancer: Immune Regulation, Biomarkers, and Immunotherapeutic Potential
by: Kaushik Das, et al.
Published: (2023-10-01)

Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
by: Silvia Mezi, et al.
Published: (2021-03-01)

Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia
by: Sumadi Lukman Anwar, et al.
Published: (2020-05-01)

A Machine Learning Model to Predict the Triple Negative Breast Cancer Immune Subtype
by: Zihao Chen, et al.
Published: (2021-09-01)

Prognostic value of androgen receptor expression in triple negative breast carcinomas: personal experience and comments on a review about “Triple-negative breast cancer: treatment challenges and solutions” by Collignon et al
by: Ieni A, et al.
Published: (2016-08-01)

Heterogeneity of triple negative breast cancer: Current advances in subtyping and treatment implications
by: Karama Asleh, et al.
Published: (2022-09-01)

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
by: Shaojun Hu, et al.
Published: (2021-11-01)

Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes
by: Trygve Lofterød, et al.
Published: (2018-06-01)

Impact of histotypes on preferential organ‐specific metastasis in triple‐negative breast cancer
by: Yaming Li, et al.
Published: (2020-02-01)

Triple negative breast cancer: special histological types and emerging therapeutic methods
by: Lu Cao, et al.
Published: (2020-05-01)

Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications
by: Shenting Liu, et al.
Published: (2023-07-01)

New research advances and future prospect in precision treatment of triple-negative breast cancer
by: XIAO Yuling, ZHU Xiuzhi, JIANG Yizhou, SHAO Zhimin
Published: (2022-08-01)

Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
by: Peter F. McAnena, et al.
Published: (2018-02-01)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
by: Yuka Asano, et al.
Published: (2017-01-01)

Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine Learning
by: Rassanee Bissanum, et al.
Published: (2021-09-01)

Heterogeneity and potential therapeutic insights for triple-negative breast cancer based on metabolic‐associated molecular subtypes and genomic mutations
by: Lijuan Li, et al.
Published: (2023-09-01)

Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancers
by: Aruna Korlimarla, et al.
Published: (2022-11-01)

Diagnosis of triple negative breast cancer based on radiomics signatures extracted from preoperative contrast-enhanced chest computed tomography
by: Qingliang Feng, et al.
Published: (2020-06-01)

Diagnostic Value of Radiomics Analysis in Contrast-Enhanced Spectral Mammography for Identifying Triple-Negative Breast Cancer
by: Yongxia Zhang, et al.
Published: (2021-12-01)

Immune checkpoints expression patterns in early-stage triple-negative breast cancer predict prognosis and remodel the tumor immune microenvironment
by: Jinguo Zhang, et al.
Published: (2023-02-01)

Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01)

Characterization of Pyroptosis-Related Subtypes via RNA-Seq and ScRNA-Seq to Predict Chemo-Immunotherapy Response in Triple-Negative Breast Cancer
by: Chenlu Li, et al.
Published: (2022-03-01)

Combination of Immune-Related Network and Molecular Typing Analysis Defines a Three-Gene Signature for Predicting Prognosis of Triple-Negative Breast Cancer
by: Jinguo Zhang, et al.
Published: (2022-10-01)